17th International Congress on Infectious Diseases
17thICID_FinalProg
17thICID_FinalProg
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<str<strong>on</strong>g>17th</str<strong>on</strong>g> INTERNATIONAL CONGRESS ON INFECTIOUS DISEASES<br />
Poster Presentati<strong>on</strong>s ~ Saturday, March 5, 2016<br />
43.119 Tuberculous osteomyelitis of mid-clavicle in<br />
a healthy normal girl<br />
A. Mudunuri<br />
Secunderabad (India)<br />
43.120 A study <strong>on</strong> factors influencing management<br />
and outcomes of tuberculosis<br />
J. R. Mutukuloju<br />
Hyderabad (India)<br />
43.121 Under-recognised and misdiagnosed; post<br />
surgical rapidly growing mycobacterial<br />
infecti<strong>on</strong>s in South India<br />
L. E. B. Nabarro, P. Rupali,<br />
J. Sarojini Michael<br />
Vellore (India)<br />
43.122 Interfer<strong>on</strong> gamma release assay (IGRA) friend<br />
or foe—Clinical applicati<strong>on</strong> of IGRA in a<br />
tuberculosis endemic country<br />
J. S. Michael 1 , B. F. B. Ascencao 2 , B. Shalini 1 ,<br />
P. Rupali 1 , M. M. Ninan 1<br />
1<br />
Vellore (India), 2 Setubal (Portugal)<br />
43.123 Outcomes of multidrug resistant tuberculosis<br />
treatment am<strong>on</strong>g human immunodeficiency<br />
virus co-infected patients taking antiretroviral<br />
treatment at Sizwe Tropical Disease<br />
Hospital Johannesburg, South Africa<br />
T. Umanah, J. Ncayiyana, X. Padanilam,<br />
P. S. Nyasulu<br />
Johannesburg (South Africa)<br />
43.124 Cellular ir<strong>on</strong> status affects drug<br />
susceptibilities and biofilm formati<strong>on</strong> of<br />
mycobacterium<br />
R. Pal, S. Hameed, Z. Fatima<br />
Gurga<strong>on</strong> (India)<br />
43.125 TRUNCATE-TB: an innovative trial design for<br />
drug-sensitive tuberculosis<br />
P. Papineni 1 , P. Phillips 2 , Q. Lu 1 ,<br />
Y. B. Cheung 1 , A. Nunn 2 , N. Pat<strong>on</strong> 1<br />
1<br />
Singapore (Singapore), 2 L<strong>on</strong>d<strong>on</strong> (United<br />
Kingdom)<br />
43.126 Identificati<strong>on</strong> of new efflux pump proteins<br />
from multidrug resistant Mycobacterium<br />
tuberculosis and screening for peptide based<br />
efflux pump inhibitors<br />
K. Parthasarathy, A. Sivaraj, R. Sundar<br />
Chennai (India)<br />
43.127 Determinants of MDR-TB in a district<br />
tuberculosis centre of a metropolitan city:<br />
A case-c<strong>on</strong>trol study<br />
A. E. Patel, L. Krishnappa, D. Rajaram,<br />
R. Kunnavil, N. S. Murthy<br />
Bengaluru (India)<br />
43.128 Mycobacterial dormancy associated proteins:<br />
Role in the survival of bacteria under stress<br />
c<strong>on</strong>diti<strong>on</strong>s<br />
V. Peddireddy, S. N. Doddam, N. Ahmed<br />
Hyderabad (India)<br />
43.129 Validati<strong>on</strong> of n<strong>on</strong>-uniform illuminati<strong>on</strong><br />
correcti<strong>on</strong> techniques in microscopic digital<br />
TB images using image sharpness measures<br />
E. Priya, S. Srinivasan<br />
Chennai (India)<br />
43.130 Paradoxical reacti<strong>on</strong> (PR) in HIV negative<br />
patients with tuberculosis: Case series<br />
A. Rajendra, K. Sabnis, J. S. Michael,<br />
P. Rupali<br />
Vellore (India)<br />
43.131 Comparative analysis of the host mediated<br />
antigen-specific resp<strong>on</strong>ses In Indian cohorts<br />
with different TB infected states<br />
S. Rakshit 1 , B. K Sundararaj 1 , P. N. Sahoo 1 ,<br />
T. H. M. Ottenhoff 2 , K. E. van Meijgaarden 2 ,<br />
A. Jesuraj 1 , G. D’Souza 1 , A. Vyakarnam 1<br />
1<br />
Bangalore (India), 2 Leiden (Netherlands)<br />
43.132 Repurposing of old drugs: Identificati<strong>on</strong> of<br />
novel sila analogues of rim<strong>on</strong>abant as potent<br />
antitubercular agents<br />
R. Ramesh 1 , R. Shingare 1 , A. Anand 2 ,<br />
S. Veeraraghavan 3 , S. Viswanadha 3 ,<br />
R. Ummanni 3 , R. Gokhale 2 , D. S. Reddy 1<br />
1<br />
Pune (India), 2 New Delhi (India),<br />
3<br />
Hyderabad (India)<br />
43.133 Orbital tuberculosis: Clinical and<br />
microbiology profile<br />
A. K. Reddy, S. Chaugule, A. Rangaiahgari,<br />
K. Mulay, S. H<strong>on</strong>avar<br />
Hyderabad (India)<br />
43.134 The urgency of effective antitubercular drug<br />
development—New promising structures<br />
derived from natural terpenoids<br />
V. V. Ruseva, G. Dobrikov<br />
Sofia (Bulgaria)<br />
43.135 Genotypes of mycobacterium tuberculosis<br />
isolated from blood of active tuberculosis<br />
patients<br />
M. Sankar, J. Singh, A. Munawwar,<br />
S. K. Kabra, R. Sood, M. Praneeth, S. Singh<br />
New Delhi (India)<br />
SATURDAY • March 5, 2016<br />
#<str<strong>on</strong>g>17th</str<strong>on</strong>g>ICID FINAL PROGRAM ~ 85